Biotech Series B Investors & VC Firms
900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.
NJF Capital
LondonSeed–Late Stage
1 person
The Wells Investment
SeoulSeed–Late Stage
WERU Investment Co. Ltd.
TokyoPre-Seed–Growth
1 person
adMare BioInnovations
VancouverPre-Seed–Series B
MSA Capital
Grand CaymanPre-Seed–Late Stage$1.4M – $130M
3 people
East West Capital Limited
SydneyPre-Seed–Late Stage
1 person
Panda Capital
Pre-Seed–Late Stage
1 person
venture / science
San Francisco Bay AreaSeed–Late Stage
1 person
BDC Climate Tech Fund II
MontréalSeed–Growth
Zhongguancun Development Group
BeijingPre-Seed–Growth
ABICO Asia Capital Corporation
TaipeiSeed–Late Stage
1 person
Bird B. AG
SchaffhausenSeed–Growth
1 person
CCV Capital
BeijingSeed–Series B
1 person
Dellin Investments
PhiladelphiaPre-Seed–Growth
5 people
Franklin Park
PhiladelphiaSeed–Late Stage
1 person
Hokkaido Venture Capital, Inc.
SapporoPre-Seed–Late Stage
1 person
Lundbeckfonden Ventures
CopenhagenPre-Seed–Late Stage
1 person
Northwell Holdings
New YorkSeed–Late Stage
1 person
Oikos Ventures
MontevideoSeed–Growth
1 person
Olima Ventures
WashingtonPre-Seed–Series B
1 person
Sherpa Healthcare Partners
Grand CaymanSeed–Late Stage
1 person
Teewinot Ventures
Pre-Seed–Late Stage
1 person
Treasure Coast Ventures
Vero BeachSeed–Growth
1 person
TriWise Capital
ShenzhenPre-Seed–Late Stage
1 person
Related lists
Series B Investors & VC Firms (4094)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Series B Investors & VC Firms in United States (1625)Biotech Series A Investors & VC Firms (1596)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.









